Brokerages Set Haleon PLC Sponsored ADR (NYSE:HLN) Price Target at $12.33

by · The Markets Daily

Haleon PLC Sponsored ADR (NYSE:HLN – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the ten analysts that are presently covering the firm, Marketbeat Ratings reports. Six investment analysts have rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company. The average 1 year target price among brokers that have issued a report on the stock in the last year is $12.3250.

HLN has been the topic of several recent analyst reports. Morgan Stanley reaffirmed an “overweight” rating on shares of Haleon in a research report on Monday, December 15th. Barclays cut shares of Haleon from an “overweight” rating to an “equal weight” rating in a research note on Tuesday, September 16th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Haleon in a research report on Wednesday, October 8th. Finally, The Goldman Sachs Group raised shares of Haleon from a “neutral” rating to a “buy” rating in a research report on Wednesday, September 10th.

Get Our Latest Stock Report on HLN

Haleon Stock Performance

Shares of HLN stock opened at $10.12 on Friday. Haleon has a 12 month low of $8.71 and a 12 month high of $11.42. The company’s fifty day simple moving average is $9.64 and its 200-day simple moving average is $9.65. The firm has a market cap of $45.07 billion, a PE ratio of 25.95 and a beta of 0.20. The company has a quick ratio of 0.63, a current ratio of 0.87 and a debt-to-equity ratio of 0.48.

Hedge Funds Weigh In On Haleon

Several institutional investors and hedge funds have recently modified their holdings of HLN. Bank of America Corp DE boosted its stake in Haleon by 116.7% in the 2nd quarter. Bank of America Corp DE now owns 12,384,135 shares of the company’s stock valued at $128,423,000 after purchasing an additional 6,669,923 shares during the period. Acadian Asset Management LLC lifted its holdings in shares of Haleon by 3,031.5% during the second quarter. Acadian Asset Management LLC now owns 5,384,661 shares of the company’s stock worth $55,813,000 after buying an additional 5,212,711 shares in the last quarter. Optiver Holding B.V. bought a new stake in shares of Haleon in the third quarter valued at about $45,593,000. Millennium Management LLC grew its position in shares of Haleon by 697.2% during the 1st quarter. Millennium Management LLC now owns 4,216,504 shares of the company’s stock worth $43,388,000 after purchasing an additional 3,687,613 shares in the last quarter. Finally, JPMorgan Chase & Co. increased its holdings in shares of Haleon by 36.6% during the third quarter. JPMorgan Chase & Co. now owns 11,984,672 shares of the company’s stock worth $107,503,000 after purchasing an additional 3,207,986 shares during the period. 6.67% of the stock is currently owned by institutional investors and hedge funds.

Haleon Company Profile

(Get Free Report)

Haleon plc (NYSE:HLN) is a global consumer healthcare company formed through the separation of a large pharmaceutical group’s consumer health business in 2022. Headquartered in the United Kingdom, Haleon develops, manufactures and markets a broad portfolio of over‑the‑counter medicines, oral health products, vitamins, minerals and supplements, and other consumer health goods designed for daily self‑care and symptom relief.

The company’s product mix spans categories such as oral care (toothpastes and sensitivity treatments), pain relief and analgesics, respiratory remedies, digestive health products, topical treatments and nutritional supplements.

See Also